Thanks, good to have some figures. Cash on hand for 4 quarters at current burn rate -- even though the cash outlay may have to increase somewhat for additional trials, there should be results from one of the clinical trials well before then, which means possibility of a partnership.

So much for the shorts claiming that the company will have to obtain dilutive financing.